STOCK TITAN

Rule 144 Notice — 35,515 Common Shares Proposed for Sale via Schwab

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 notice for proposed sale of common stock. The filing shows 35,515 shares of common stock are proposed for sale through The Charles Schwab Corporation, with an aggregate market value of $108,451 and 8,067,580 shares outstanding. The securities were acquired as compensation on 02/15/2024 in a transaction described as "COMPENSATION / DEAL ACQUIRED BETWEEN: 2/15/24 TO 11/5/24" and payment is recorded as of 02/15/2024. The filer reports no securities sold during the past three months. The notice includes the standard representation that the seller is not aware of any undisclosed material adverse information.

Positive

  • Full Rule 144 disclosure provided including acquisition date, source, broker, number of shares, and aggregate market value
  • No sales reported in the past three months, indicating this is a single planned transaction rather than ongoing disposals

Negative

  • None.

Insights

TL;DR: Routine Rule 144 notice documenting a planned sale of previously acquired compensation shares via a broker.

The filing documents a proposed public sale under Rule 144 of 35,515 common shares executed through The Charles Schwab Corporation with an aggregate market value of $108,451. The acquisition is dated 02/15/2024 and described as compensation; the seller certifies no undisclosed material adverse information. There are no reported sales in the prior three months, which is consistent with a single planned transaction under Rule 144 rather than an ongoing disposal program. From a compliance perspective, the notice satisfies basic disclosure elements required by Rule 144, including acquisition source, date, number of shares, and broker details.

TL;DR: Transaction size is modest relative to outstanding shares and is unlikely to be materially market-moving.

The proposed sale of 35,515 shares represents a small fraction of the 8,067,580 shares reported outstanding. At an aggregate market value of $108,451, this disposal appears modest in scale and more consistent with routine monetization of compensation rather than a large-scale insider exit. The absence of any sales in the prior three months further suggests this is an isolated planned sale. Investors should note the filing documents a planned sale but contains no forward-looking or operational information about the issuer.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filed for NXGL/NEXGEL, INC. report?

The filing reports a proposed sale of 35,515 common shares with an aggregate market value of $108,451, to be executed through The Charles Schwab Corporation.

When were the shares to be sold acquired?

The shares were acquired on 02/15/2024 and are described as acquired as compensation.

How large is the proposed sale relative to outstanding shares?

The filing shows 8,067,580 shares outstanding; the proposed 35,515 share sale is a small percentage of the outstanding shares.

Were any shares sold by the filer in the past three months?

The filing states Nothing to Report for securities sold during the past three months.

Which broker is handling the proposed sale?

The proposed sale is to be handled by The Charles Schwab Corporation located at 3000 Schwab Way, Westlake TX 76262.
Nexgel Inc

NASDAQ:NXGL

View NXGL Stock Overview

NXGL Rankings

NXGL Latest News

NXGL Latest SEC Filings

NXGL Stock Data

7.75M
6.90M
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
LANGHORNE